Cooper DL - Search Results

1

Use of recombinant activated factor VII in patients with Glanzmann's thrombasthenia: a review of the literature.

Rajpurkar M, Chitlur M, Recht M, Cooper DL. Rajpurkar M, et al. Among authors: cooper dl. Haemophilia. 2014 Jul;20(4):464-71. doi: 10.1111/hae.12473. Haemophilia. 2014. PMID: 24948404 Review.

2

Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004-2008).

Nakar C, Cooper DL, DiMichele D. Nakar C, et al. Among authors: cooper dl. Haemophilia. 2010 Jul 1;16(4):625-31. doi: 10.1111/j.1365-2516.2010.02208.x. Epub 2010 Feb 10. Haemophilia. 2010. PMID: 20158526

3

Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX.

Valentino LA, Cooper DL, Goldstein B. Valentino LA, et al. Among authors: cooper dl. Haemophilia. 2011 Jul;17(4):579-89. doi: 10.1111/j.1365-2516.2010.02460.x. Epub 2011 Feb 7. Haemophilia. 2011. PMID: 21294815 Review.

4

Exposure and safety of higher doses of recombinant factor VIIa ≥250 μg kg(-1) in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004-2008).

Neufeld EJ, Kessler CM, Gill JC, Wilke CT, Cooper DL; Htrs Investigators. Neufeld EJ, et al. Among authors: cooper dl. Haemophilia. 2011 Jul;17(4):650-6. doi: 10.1111/j.1365-2516.2010.02483.x. Epub 2011 Feb 7. Haemophilia. 2011. PMID: 21299750

5

Patient/caregiver-reported recombinant factor VIIa (rFVIIa) dosing: home treatment of acute bleeds in the Dosing Observational Study in Hemophilia (DOSE).

Young G, Shapiro AD, Walsh CE, Gruppo RA, Gut RZ, Cooper DL. Young G, et al. Among authors: cooper dl. Haemophilia. 2012 May;18(3):392-9. doi: 10.1111/j.1365-2516.2011.02704.x. Epub 2011 Dec 16. Haemophilia. 2012. PMID: 22171621

6

Patient- and caregiver-reported bleeding symptoms and reasons for starting and stopping treatment with recombinant factor VIIa: analysis of the Dosing Observational Study in Haemophilia (DOSE).

Valentino LA, Walsh CE, Reding MT, Young GA, Levendoglu-Tugal O, Cooper DL. Valentino LA, et al. Among authors: cooper dl. Haemophilia. 2012 Jul;18(4):554-60. doi: 10.1111/j.1365-2516.2012.02762.x. Epub 2012 Feb 20. Haemophilia. 2012. PMID: 22348407

7

Dosing and effectiveness of recombinant activated factor VII (rFVIIA) in congenital haemophilia with inhibitors by bleed type and location: the experience of the Haemophilia and Thrombosis Research Society (HTRS) Registry (2004-2008).

Young G, Cooper DL, Gut RZ; HTRS Investigators. Young G, et al. Among authors: cooper dl. Haemophilia. 2012 Nov;18(6):990-6. doi: 10.1111/j.1365-2516.2012.02864.x. Epub 2012 May 28. Haemophilia. 2012. PMID: 22631073

8

Effect of acute bleeding on daily quality of life assessments in patients with congenital hemophilia with inhibitors and their families: observations from the dosing observational study in hemophilia.

Neufeld EJ, Recht M, Sabio H, Saxena K, Solem CT, Pickard AS, Gut RZ, Cooper DL. Neufeld EJ, et al. Among authors: cooper dl. Value Health. 2012 Sep-Oct;15(6):916-25. doi: 10.1016/j.jval.2012.05.005. Value Health. 2012. PMID: 22999142 Free article.

9

Assessment of individual dose utilization vs. physician prescribing recommendations for recombinant activated factor VII (rFVIIa) in paediatric and adult patients with congenital haemophilia and alloantibody inhibitors (CHwI): the Dosing Observational Study in Hemophilia (DOSE).

Gruppo RA, Kessler CM, Neufeld EJ, Cooper DL. Gruppo RA, et al. Among authors: cooper dl. Haemophilia. 2013 Jul;19(4):524-32. doi: 10.1111/hae.12113. Epub 2013 Apr 1. Haemophilia. 2013. PMID: 23551918

10

Safety of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors: overall rFVIIa exposure and intervals following high (>240 μg kg⁻¹) rFVIIa doses across clinical trials and registries.

Shapiro AD, Neufeld EJ, Blanchette V, Salaj P, Gut RZ, Cooper DL. Shapiro AD, et al. Among authors: cooper dl. Haemophilia. 2014 Jan;20(1):e23-31. doi: 10.1111/hae.12329. Haemophilia. 2014. PMID: 24354484

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

372 results

Search Page